Ning XH - Search Results

1

Engineering bacterial outer membrane vesicles as transdermal nanoplatforms for photo-TRAIL-programmed therapy against melanoma.

Peng LH, Wang MZ, Chu Y, Zhang L, Niu J, Shao HT, Yuan TJ, Jiang ZH, Gao JQ, Ning XH. Peng LH, et al. Among authors: ning xh. Sci Adv. 2020 Jul 3;6(27):eaba2735. doi: 10.1126/sciadv.aba2735. eCollection 2020 Jul. Sci Adv. 2020. PMID: 32923586 Free PMC article.

2

A sensitive and fast responsive fluorescent probe for imaging hypoxic tumors.

Zhang L, Shan X, Guo L, Zhang J, Ge J, Jiang Q, Ning X. Zhang L, et al. Analyst. 2018 Dec 17;144(1):284-289. doi: 10.1039/c8an01472h. Analyst. 2018. PMID: 30402622

3

An elegant nitroreductase responsive fluorescent probe for selective detection of pathogenic Listeria in vitro and in vivo.

Zhang L, Guo L, Shan X, Lin X, Gu T, Zhang J, Ge J, Li W, Ge H, Jiang Q, Ning X. Zhang L, et al. Talanta. 2019 Jun 1;198:472-479. doi: 10.1016/j.talanta.2019.02.026. Epub 2019 Feb 6. Talanta. 2019. PMID: 30876589

4

Novel Integrin αvβ3-Specific Ligand for the Sensitive Diagnosis of Glioblastoma.

Zhang L, Shan X, Meng X, Gu T, Guo L, An X, Jiang Q, Ge H, Ning X. Zhang L, et al. Mol Pharm. 2019 Sep 3;16(9):3977-3984. doi: 10.1021/acs.molpharmaceut.9b00602. Epub 2019 Jul 29. Mol Pharm. 2019. PMID: 31306580

5

Integrin αvβ3-Specific Hydrocyanine for Cooperative Targeting of Glioblastoma with High Sensitivity and Specificity.

Zhang L, Meng X, Shan X, Gu T, Zhang J, Feng S, An X, Chen J, Jiang Q, Ning X. Zhang L, et al. Anal Chem. 2019 Oct 1;91(19):12587-12595. doi: 10.1021/acs.analchem.9b03725. Epub 2019 Sep 20. Anal Chem. 2019. PMID: 31496223

6

The first integrins β3-mediated cellular and nuclear targeting therapeutics for prostate cancer.

Zhang L, Shan X, Meng X, Gu T, Lu Q, Zhang J, Chen J, Jiang Q, Ning X. Zhang L, et al. Biomaterials. 2019 Dec;223:119471. doi: 10.1016/j.biomaterials.2019.119471. Epub 2019 Sep 4. Biomaterials. 2019. PMID: 31525693

7

A stimuli-responsive combination therapy for recovering p53-inactivation associated drug resistance.

Guo L, Xu Y, Zhou A, Zhang L, Sun L, Gao Y, Chen J, Shan X, Zhang J, Ge J, An X, Liu X, Zhang Y, Ning X. Guo L, et al. Mater Sci Eng C Mater Biol Appl. 2020 Mar;108:110403. doi: 10.1016/j.msec.2019.110403. Epub 2019 Nov 6. Mater Sci Eng C Mater Biol Appl. 2020. PMID: 31923941

8

An octopus-mimic PEGylated peptide as a specific integrin αvβ3 inhibitor for preventing tumor progression.

Shan X, Zhang L, Xu Y, Sun L, Guo L, Feng S, Ge H, Gu T, Ning X. Shan X, et al. Chem Commun (Camb). 2020 Feb 18;56(14):2178-2181. doi: 10.1039/c9cc09496b. Epub 2020 Jan 23. Chem Commun (Camb). 2020. PMID: 31971174

9

Smart pH-Sensitive Nanogels for Enhancing Synergistic Anticancer Effects of Integrin α_vβ₃ Specific Apoptotic Peptide and Therapeutic Nitric Oxide.

Xu Y, Sun L, Feng S, Chen J, Gao Y, Guo L, An X, Nie Y, Zhang Y, Liu X, Ning X. Xu Y, et al. ACS Appl Mater Interfaces. 2019 Sep 25;11(38):34663-34675. doi: 10.1021/acsami.9b10830. Epub 2019 Sep 16. ACS Appl Mater Interfaces. 2019. PMID: 31490654

10

Multistage targeted "Photoactive neutrophil" for enhancing synergistic photo-chemotherapy.

Xu Y, Zhang X, Hu G, Wu X, Nie Y, Wu H, Kong D, Ning X. Xu Y, et al. Biomaterials. 2021 Dec;279:121224. doi: 10.1016/j.biomaterials.2021.121224. Epub 2021 Oct 22. Biomaterials. 2021. PMID: 34710792

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters